Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Financial Statements
- Click here to download Abiomed Inc.'s Income Statement
- Click here to download Abiomed Inc.'s Balance Sheet
- Click here to download Abiomed Inc.'s Statement of Cash Flows
Key Info
- Industry: Surgical and Medical Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Michael Minogue
Key Statistics
- Stock Price: $245.66
- Dividend Yield: 0%
- Market Capitalization: $11,358,996,429
- Shares Outstanding: 45,625,789
- Number of Employees: 1,725
- Trailing 12-Month EPS: $4.73
- Trailing 12-Month DPS: $0
- Payout Ratio: 0.0%
Important Dates
- Next Earnings Date: 2022-10-27
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $245.66
- 52-week high: $379.3
- 52-week low: $219.85
- 200-day moving average: $274.27
- 50-day moving average: $264.73
Performance
- 1-Month Price Return: -3.1%
- 3-Month Price Return: -2.9%
- 6-Month Price Return: -24.9%
- 1-Year Price Return: -24.4%
- 2-Year Price Return: -8.6%
- 5-Year Price Return: 47.7%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast